Daitaro Kurosaka Selected Research

Fasciitis (Fascitis)

1/2018	Fasciitis as a disease manifestation in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies: a case report of two cases.
12/2017	Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis.
1/2017	Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations.
12/2010	Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daitaro Kurosaka Research Topics

Disease

6	Rheumatoid Arthritis 06/2019 - 01/2006
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2007 - 01/2003
4	Arthritis (Polyarthritis) 12/2019 - 09/2005
4	Fasciitis (Fascitis) 01/2018 - 12/2010
3	Dermatomyositis (Dermatopolymyositis) 12/2017 - 01/2006
2	Pain (Aches) 11/2022 - 09/2020
2	Inflammation (Inflammations) 12/2019 - 12/2017
2	Experimental Arthritis 12/2019 - 04/2009
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 12/2017
2	Neoplasms (Cancer) 01/2017 - 01/2004
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2017 - 01/2007
1	Congenital Abnormalities (Deformity) 12/2019
1	Muscular Diseases (Myopathy) 01/2018
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2017
1	Myalgia 01/2017
1	Muscle Weakness 01/2017
1	Measles 01/2010
1	Virus Diseases (Viral Diseases) 01/2010
1	Reinfection 01/2010
1	Bacterial Infections (Bacterial Infection) 01/2010
1	Subcutaneous Emphysema 07/2008
1	Mediastinal Emphysema (Pneumomediastinum) 07/2008
1	Macrocytic Anemia 01/2007
1	Infections 01/2007
1	Cough 01/2007
1	Lymphopenia (Lymphocytopenia) 01/2007
1	Pancytopenia 01/2007
1	Hypoxia (Hypoxemia) 01/2007
1	Megaloblastic Anemia 01/2007
1	Thrombocytopenia (Thrombopenia) 01/2007
1	Fatigue 01/2007
1	Bacterial Pneumonia 01/2007
1	Evans Syndrome 01/2007
1	Cryofibrinogenemia 01/2007
1	Psoriatic Arthritis 01/2006
1	Ankylosing Spondylitis 01/2006
1	Systemic Scleroderma (Systemic Sclerosis) 01/2006
1	Knee Osteoarthritis 01/2006
1	Polymyositis 01/2006

Drug/Important Bio-Agent (IBA)

5	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2019 - 01/2003
5	AntibodiesIBA 01/2018 - 01/2006
4	Collagen Type II (Type II Collagen)IBA 05/2014 - 09/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 01/2009
2	AutoantibodiesIBA 01/2019 - 01/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2010 - 01/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010 - 01/2007
2	Immunoglobulin M (IgM)IBA 01/2010 - 01/2007
1	Prostaglandins AIBA 11/2022
1	propylene diquat (PDQ(+))IBA 09/2020
1	tofacitinibIBA 12/2019
1	Antirheumatic Agents (DMARD)IBA 12/2019
1	Abatacept (Orencia)FDA Link 06/2019
1	GadoliniumIBA 01/2019
1	Signal Recognition ParticleIBA 01/2018
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 12/2017
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2017
1	Therapeutic UsesIBA 05/2014
1	Tyrosine (L-Tyrosine)FDA Link 05/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2014
1	Angiogenesis InhibitorsIBA 05/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2014
1	Phosphotransferases (Kinase)IBA 05/2014
1	Sunitinib (Sutent)FDA Link 05/2014
1	Aligeron (AS 2)IBA 12/2010
1	Angiopoietin-2IBA 06/2010
1	Angiopoietin-1IBA 06/2010
1	Etanercept (Enbrel)FDA Link 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	Peptides (Polypeptides)IBA 04/2009
1	Messenger RNA (mRNA)IBA 04/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2008
1	Indicators and Reagents (Reagents)IBA 01/2007
1	Pharmaceutical PreparationsIBA 01/2007
1	Cholestyramine Resin (Questran)FDA LinkGeneric 01/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2007
1	SteroidsIBA 01/2007
1	Leflunomide (Arava)FDA LinkGeneric 01/2007
1	AntigensIBA 01/2006
1	BuffersIBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2007 - 01/2007
1	Drug Therapy (Chemotherapy) 12/2019